Janssen Pharmaceutica N.v., Belgium
Clinical trials sponsored by Janssen Pharmaceutica N.v., Belgium, explained in plain language.
-
Race to stop Alzheimer's before it starts: new vaccine enters major trial
Disease control OngoingThis study is testing whether an experimental vaccine can slow or prevent cognitive decline in people who have early Alzheimer's-related brain changes but no memory symptoms yet. About 500 participants will receive either the vaccine or a placebo and be followed for about 4 years…
Phase: PHASE2 • Sponsor: Janssen Pharmaceutica N.V., Belgium • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Major 6-Year study tracks how well arthritis patients stick with their medications
Disease control OngoingThis study is observing over 1,300 people with psoriatic arthritis who are starting one of two types of injectable medications (guselkumab or an IL-17 inhibitor) as part of their regular doctor's care. The main goal is to see how long patients continue taking these medications an…
Sponsor: Janssen Pharmaceutica N.V., Belgium • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope to stop prostate cancer spread in High-Risk patients
Disease control OngoingThis large, late-stage study is testing if adding the drug apalutamide to standard radiation and hormone therapy is better at delaying the spread of prostate cancer in high-risk patients who have already had surgery. It will involve about 693 men and use advanced PET scans to clo…
Phase: PHASE3 • Sponsor: Janssen Pharmaceutica N.V., Belgium • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC